IN INJ Injective Loading... : Bullish and Bearish Analyst Opinions

Author discloses a current long position in INJ and endorses the parent screener signal that INJ is a runner up 20%.

Buy INJ as it trades with top-100 volume without top-100 status, indicating strong accumulation and potential index/benchmark inclusion as it climbs.

POSCO International, South Korea’s largest trading company, is piloting tokenized trade receivables on Injective with LG CNS. The initiative targets cross-border settlement pain points, which account for 84% of POSCO’s revenue, and aims to reduce settlement time from 30–90 days to 600 milliseconds. Eric Chen expects the pilot to trigger a gradual expansion, then a sudden ‘everything at once’ overhaul once effectiveness is proven, opening floodgates where POSCO moves the majority of its transactions and settlements to Injective’s infrastructure stack, which would drive massive network usage and demand for the INJ token.

POSCO International's pilot tokenizing trade receivables on Injective could lead to a full-scale overhaul where the company moves the majority of its cross-border transactions and settlement onto Injective, dramatically increasing network usage and potentially boosting INJ token value.

The tweet expresses a bullish sentiment toward Injective by suggesting that the market should increase its valuation of the asset.